Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 09:32 am Sale | 2022-12-31 | 13G | KURA ONCOLOGY INC KURA | Avoro Capital Advisors LLC | 3,105,000 4.500% | -895,000![]() (-22.38%) | Filing History |
| 2023-02-14 09:32 am Purchase | 2022-12-31 | 13G | DICE THERAPEUTICS INC DICE | Avoro Capital Advisors LLC | 2,525,555 5.300% | 2,525,555![]() (New Position) | Filing History |
| 2023-02-14 09:31 am Sale | 2022-12-31 | 13G | IOVANCE BIOTHERAPEUTICS INC CO IOVA | Avoro Capital Advisors LLC | 7,020,000 4.400% | -1,655,000![]() (-19.08%) | Filing History |
| 2023-02-14 09:30 am Sale | 2022-12-31 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Avoro Capital Advisors LLC | 0 0.000% | -695,000![]() (Position Closed) | Filing History |
| 2022-09-26 5:27 pm Purchase | 2022-09-22 | 13D | WHITEHAWK THERAPEUTICS, INC. C WHWK | Avoro Capital Advisors LLC | 3,471,752 14.400% | 1,260,000![]() (+56.97%) | Filing History |
| 2022-02-11 10:09 am Sale | 2021-12-31 | 13G | POINT BIOPHARMA GLOBAL INC PNT | Avoro Capital Advisors LLC | 0 0.000% | -1,000,000![]() (Position Closed) | Filing History |
| 2022-02-11 10:08 am Sale | 2021-12-31 | 13G | RELMADA THERAPEUTICS INC P RLMD | Avoro Capital Advisors LLC | 0 0.000% | -1,525,000![]() (Position Closed) | Filing History |
| 2022-02-11 10:08 am Sale | 2021-12-31 | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Avoro Capital Advisors LLC | 1,200,000 4.600% | -470,000![]() (-28.14%) | Filing History |
| 2022-02-11 10:07 am Sale | 2021-12-31 | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Avoro Capital Advisors LLC | 1,670,000 2.900% | -2,695,000![]() (-61.74%) | Filing History |
| 2022-02-11 10:07 am Sale | 2021-12-31 | 13G | ARENA PHARMACEUTICALS INC ARNA | Avoro Capital Advisors LLC | 1,235,000 2.000% | -2,955,000![]() (-70.53%) | Filing History |
| 2022-02-11 10:06 am Sale | 2021-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | Avoro Capital Advisors LLC | 1,465,000 3.200% | -885,267![]() (-37.67%) | Filing History |
| 2022-02-11 10:06 am Purchase | 2021-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Avoro Capital Advisors LLC | 3,311,434 7.100% | 3,311,434![]() (New Position) | Filing History |
| 2022-02-11 10:05 am Purchase | 2021-12-31 | 13G | AMICUS THERAPEUTICS INC FOLD | Avoro Capital Advisors LLC | 18,500,000 6.600% | 7,300,000![]() (+65.18%) | Filing History |
| 2022-02-11 10:05 am Purchase | 2021-12-31 | 13G | IO BIOTECH INC IOBTQ | Avoro Capital Advisors LLC | 2,055,883 7.100% | 2,055,883![]() (New Position) | Filing History |
| 2022-02-11 10:04 am Purchase | 2021-12-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Avoro Capital Advisors LLC | 8,555,555 8.900% | 8,555,555![]() (New Position) | Filing History |
| 2022-02-11 10:04 am Purchase | 2021-12-31 | 13G | IOVANCE BIOTHERAPEUTICS INC CO IOVA | Avoro Capital Advisors LLC | 8,675,000 5.500% | 1,175,000![]() (+15.67%) | Filing History |
| 2022-02-11 10:03 am Purchase | 2021-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | Avoro Capital Advisors LLC | 1,425,000 8.300% | 200,000![]() (+16.33%) | Filing History |
| 2022-02-11 10:03 am Purchase | 2021-12-31 | 13G | CYMABAY THERAPEUTICS INC CBAY | Avoro Capital Advisors LLC | 12,800,000 14.700% | 2,500,000![]() (+24.27%) | Filing History |
| 2022-02-11 10:02 am Purchase | 2021-12-31 | 13G | UNITED THERAPEUTICS CORP UTHR | Avoro Capital Advisors LLC | 3,035,000 6.700% | 185,000![]() (+6.49%) | Filing History |
| 2022-02-11 10:01 am Sale | 2021-12-31 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Avoro Capital Advisors LLC | 695,000 7.100% | -105,000![]() (-13.13%) | Filing History |

